Market research
603259.SHG WuXi AppTec Co., Ltd
SHG CNY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 486B
- P/E ratio
- 22.07
- Analyst target
- 182.5339
- Dividend yield
- 1.2%
- Beta
- 0.46
Profile
Company facts
- Exchange
- SHG
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- CNE1000031K4
- Market cap
- 486B
- P/E ratio
- 22.07
- Analyst target
- 182.5339
- Dividend yield
- 1.2%
- Beta
- 0.46
About
About WuXi AppTec Co., Ltd
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization. In addition, it offers services for biology; CDRMO platform for small molecules, oligonucleotides, and peptides; drug research and development testing; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 603259.SHG discussion.
5 years, 5 months ago
WuXi AppTec Co., Ltd is currently in a long term uptrend where the price is trading 32.3% above its 200 day moving average.
From a valuation standpoint, the stock is 110.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 20.3.
WuXi AppTec Co., Ltd's total revenue rose by 31.4% to $5B since the same quarter in the previous year.
Its net income has increased by 562.0% to $592M since the same quarter in the previous year.
Finally, its free cash flow fell by 0.4% to $441M since the same quarter in the previous year.
Based on the above factors, WuXi AppTec Co., Ltd gets an overall score of 3/5.